• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

New antihistamine eye drop controls itchy eyes

Article

Schering-Plough Corp. has launched an antihistamine eye drop (Claritin Eye) designed to control the itch of allergy eyes for up to 12 hours.

Kenilworth, NJ

-Schering-Plough Corp. has launched an antihistamine eye drop (Claritin Eye) designed to control the itch of allergy eyes for up to 12 hours.

“Itchy eyes are an extremely bothersome symptom for allergy sufferers and can be caused by indoor or outdoor allergens, such as dust, pet dander, mold, or pollen. [The antihistamine eye drop] relieves the itch at the source by blocking the histamine that causes itchy eyes,” said John O’Mullane, PhD, group vice president, research and development, Schering-Plough Consumer HealthCare.

The makers of the drop have launched a national advertising campaign to support the introduction of the product, according to a prepared statement. In addition, the brand’s newly launched Facebook page,

www.facebook.com/claritineye

, offers facts and tips for those who experience allergies. The page also features an “eye makeover” tool that allows consumers to upload photographs and use the application to clear the red eye in their pictures.

The drop is available without a prescription and can be found in most food, drug, and mass retailers.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.